SIRT1 and diabetes mellitus: Consequently, SIRT1 dysregulation has been implicated in diabetes and thereby, it may be considered as a therapeutic target for some debilitating diseases, for example, neurodegeneration, osteoarthritis, cardiovascular disease, and diabetic complications [17, 28, 29, 30, 31, 32, 33, 34].